scholarly journals Frequency of peripheral neuropathy in newly diagnosed cases of type II diabetes mellitus.

2021 ◽  
Vol 28 (10) ◽  
pp. 1443-1446
Author(s):  
Altaf Ahmad Yar ◽  
Munaza Javed ◽  
Muzamul Shahzad ◽  
Javed Iqbal ◽  
Muhammad Imran Aslam ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Peripheral Neuropathy ◽  
Blood Sugar ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Cross Sectional Study ◽  
Type Ii ◽  
Newly Diagnosed ◽  
Cross Sectional

Objective: The aim of this study is to determine the frequency of peripheral neuropathy in newly diagnosed cases of type II diabetes mellitus. Study Design: Cross Sectional Study. Setting: Department of Medicine at Avicenna Medical & Dental College, Lahore. Period: 1st February 2020 to 31st July 2020. Material & Methods: One hundred and twenty newly diagnosed patients of type 2 diabetes mellitus were enrolled in this study. Patients detailed demographically recorded after getting written consent. Patients were diagnosed for the duration of 4-weeks and calculated fasting blood sugar (FBS) of ≥126mg/dl, and Random Blood Sugar (RBS) of ≥200 mg/dl or HbA1c ≤6.5. Results: Seventy (58.3%) were males and rest 50 (41.7%) were females with mean age 37.15±10.91 years. Mean body mass index of the patients was 22.48±3.66 kg/m2. Forty two (35%) patients had symptoms of peripheral neuropathy while that patient’s who did not have any symptom was 78 (65%). Same symptoms were observed within 4-weeks and we noticed that 23 (19.2%) patients showed peripheral neuropathy and rest 97 (80.8%) patients did not have any symptoms. Conclusion: The frequency of peripheral neuropathy is higher in early stages of type II diabetes mellitus and its frequency can be reduced to diagnose within a month.

scholarly journals Peripheral Neuropathy in Newly Diagnosed Cases of Type II Diabetes Mellitus

2019 ◽  
Vol 23 (3) ◽  
pp. 234-238
Author(s):  
NAZ AKRAM ◽  
AMBREEN BUTT ◽  
KHADIJA WAHEED
Keyword(s):  
Diabetes Mellitus ◽  
Peripheral Neuropathy ◽  
Type Ii Diabetes ◽  
Previous History ◽  
Type Ii Diabetes Mellitus ◽  
Cross Sectional Study ◽  
Type Ii ◽  
Newly Diagnosed ◽  
Cross Sectional ◽  
Age Range

Objective: Diabetes mellitus linked to severe macrovascular and the microvescular complications. Diabetic peripheral neuropathy is the challenging complication of the diabetes mellitus, which is linked to the morbidity, mortality, and big economic burden. We determined the frequency of peripheral neuropathy in newly diagnosed cases of type II diabetes mellitus.Materials & Methods: The current descriptive Cross Sectional study took place in Services Institute of Medical Sciences, Lahore, From June 2014 to January 2015. All the patients, those were newly diagnosed with diabetes mellitus, aged 30-60 years and both genders were included. Detailed history regarding diabetes was taken. Patients underwent for the evaluation of peripheral neuropathy by taking physical examination, previous history and vibration perception test. All the data was recorded in the Proforma.Results: Total 150 cases were studied, out of them, 42.67% were aged 30-45 years while 57.33% were in the age range of 46-60 years and their overall mean age was 46.35 ± 9.52 years. Males were 54.0% and females were 46.0%. Frequency of peripheral neuropathy for newly diagnosed type II diabetic subjects was noted 20.67%, with insignificant association of age and gender.Conclusion: It was concluded that the peripheral neuropathy was 20.67% among patients newly diagnosed with diabetes mellitus.

scholarly journals Clinical evaluation of an Ayurvedic Formulation in the management of Avaranajanya Madhumeha (Type 2 Diabetes Mellitus)

2019 ◽  
Vol 1 ◽  
pp. 50-64
Author(s):  
DEVASHISH BHARDWAJ ◽  
VEENIT K. AGNIHOTRI ◽  
PRANAV PANDYA
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Blood Sugar ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii ◽  
Research Plan ◽  
Urine Sugar ◽  
Diabetes Patients

A research plan has been developed in the present study to address the problems associated with Avaranajanya Madhumeha (type 2 diabetes). This research plan is based on the treatment methods of Ayurveda (ancient Indian medicine) and utilization of modern scientific methods as research tools. A specific ayurvedic herbo-mineral formulation has been prepared in Ghansatt (solid extract) form; the selected eight herbs and one herbo-mineral have anti-hyperglycemic (PRAMEHA HARA) and antihypercholestermic (MEDOHARA) properties with rejuvenative (RASAYANA) effects as described in classical ayurvedic methods. 15 diagnosed type II diabetes mellitus patients were selected through accidental sampling. Ayurvedic formulation was prescribed to type II diabetes patients for one year along with dietary restrictions. Diabetic diagnostic parameters of these patients like Fasting Blood Sugar (FBS), Post Patrum Blood Sugar (PPBS), Glycocylated Hemoglobin (HbA1C) and Urine Sugar Fasting were monitored every three months; these were measured before and after intervention. The obtained data were statistically analyzed through paired t-test. There was significant reduction in FBS level, PPBS level, HbA1C level and urine fasting sugar level in type 2 diabetes patients who completed the clinical trial successfully. Thus, ayurvedic formulation treatment lead to an overall significant reduction in blood sugar and urine sugar levels in type II diabetes patients. No side effects were noted during the study period. This study suggests that the ayurvedic formulation had very good hypoglycemic effects proved by clinical improvement and bio-chemical analysis of diabetes parameters in the treatment of type II diabetes mellitus.

scholarly journals Evaluation of sweet taste sensitivity in type-II Diabetes Mellitus patients

2020 ◽  
pp. 10-12
Author(s):  
Z. Naveen Kumar ◽  
B.N.S. Gowri Kumari
Keyword(s):  
Diabetes Mellitus ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Sweet Taste ◽  
Cross Sectional Study ◽  
Taste Sensitivity ◽  
Diabetic Patients ◽  
Type Ii ◽  
Cross Sectional ◽  
The Mean

Background: The objective is to evaluate the sweet taste sensitivity among type-II diabetes mellitus patients. Methods:  This is a cross sectional study consisted of 227 subjects (127 type-II Diabetic patients & 100 non diabetic individuals) of both the genders and age matched. Sweet taste sensitivity tests were done using different concentrations of glucose solution and compared among the diabetic patients with FBS more than 180mg/dl and diabetic patients with FBS less than 180mg/dl and also compared among the diabetic patients and non diabetic individuals.  The final concentration at which patient was able to perceive the taste was recorded. statistical analysis was done using Student’s unpaired T test. P­values of < 0.05 were considered to be statistically significant. Results: The mean of sweet taste sensitivity among diabetic patients with FBS >180 mg/dl was 6245 mg/l and the mean of sweet taste sensitivity in the diabetic patients with FBS <180 mg/dl was 2249mg/l with P<0.001 which is significant. The mean of sweet taste sensitivity among diabetic patients with FBS >180 mg/dl was 6245mg/l and the mean of sweet taste sensitivity in the non diabetic individuals was 1979mg/l with P<0.01 which is significant. the mean of sweet taste sensitivity among diabetic patients with FBS <180 mg/dl was 2249 mg/l and the mean of sweet taste sensitivity in the non diabetic individuals was 1979mg/l  with P>0.05 which is not significant. Conclusion: In our study it was concluded that type-II Diabetes Mellitus patients have lesser sensitivity for the sweet taste. Loss of sensitivity leads to the increase in sugar consumption being the risk factor for worsening the disease.

scholarly journals Newly diagnosed type II diabetes mellitus presenting with localized itch

2020 ◽  
Vol 8 (5) ◽  
pp. 1878
Author(s):  
Talib Mearza ◽  
Wesam Abou Amer ◽  
Maryam Al Jaber
Keyword(s):  
Diabetes Mellitus ◽  
Insulin Resistance ◽  
Dietary Intake ◽  
Blood Sugar ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii ◽  
Newly Diagnosed ◽  
Cutaneous Manifestations ◽  
Sugar Levels

Type II diabetes is caused by insulin resistance resulting in high blood sugar levels. Although the typical symptoms of diabetes are described as polyuria, polydipsia and fatigue as many as 60% of newly diagnosed patients with type II diabetes are asymptomatic. Here authors present a case of a 39-year-old male patient who presented with localized pruritus affecting the medial aspects of his forearms and upper legs as the sole symptom of newly diagnosed type II diabetes mellitus. The itch symptom markedly improved on significantly reducing his dietary intake of sugars and with the use of metformin. Authors hope to alert clinicians to consider the possibility of underlying diabetes in such presentations to enable swift diagnosis and consequent treatment. It is unusual to find patients presenting with localized itch without any corresponding cutaneous manifestations as a presentation of type II diabetes.

CLINICAL STUDY TO EVALUATE EFFICACY OF NISHA AMALAKI CHURNA IN NEWLY DIAGNOSED PRAMEHA TYPE II DIABETES MELLITUS.

2021 ◽  
pp. 42-43
Author(s):  
Neena Damle
Keyword(s):  
Diabetes Mellitus ◽  
Blood Sugar ◽  
Type Ii Diabetes ◽  
Blood Sugar Level ◽  
Type Ii Diabetes Mellitus ◽  
Fasting Blood Sugar ◽  
Type Ii ◽  
Newly Diagnosed ◽  
Sugar Levels ◽  
Hba1c Levels

During the last few years India have maximum increase of Type II diabetes mellitus . The prevalence of type 2 diabetes mellitus is 2.4% in rural population and 11.6% in urban population[1] . In this study total 10 Subjects of newly diagnosed type II Diabetes Mellitus, who fullled below criteria were selected from D.Y. Patil Ayurvedic Hospital Nerul Navi Mumbai OPD No.1. a) HbA1c level more than 6.5% b) Fasting blood Sugar level (FBS) more than 126 mg/dL (7 mmol/L) c) 2-hour Post Prandial Blood Sugar level (PPBS) more than 200 mg/dL (11.1 mmol/L). All 10 subjects treated with Nisha Amalaki Churna 3gms BD one hour before breakfast and before dinner with warm water for three months. Data of subjective parameters and physical examination of subjects was recorded in CRF during three visits 30 days apart. For Statistical Analysis Wilcoxon matched-pairs signed-ranks test was used to assess Subjective parameters and Paired t-Test was used to compare Fasting Blood Sugar level, two hour post prandial blood sugar levels and HbA1C levels BT and AT. The study showed signicant results in most of the subjective parameters at the level of signicance (P<0.05). Nisha Amalaki Churna reduced Fasting blood sugar levels and post Prandial blood sugar levels signicantly at level of signicance p<0.01. Nisha Amalaki Churna also reduced HbA1C levels signicantly at level of signicance p<0.01.The Ayurvedic mixture Nisha Amalaki Churna was signicantly effective in newly diagnosed Type II Diabetes Mellitus subjects.

Sign in / Sign up

Export Citation Format

Share Document